30 phenotypes from 5 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Ago2Gt(XE344)Byg/Ago2Gt(XE344)Byg involves: 129P2/OlaHsd * C57BL/6	abnormal embryonic tissue morphology	J:121791
	normal cellular phenotype	J:121791
	embryonic growth arrest	J:121791
	embryonic lethality between implantation and somite formation, complete penetrance	J:121791
Ago2Gt(XE344)Byg/Ago2tm2Ghan involves: 129P2/OlaHsd	placental labyrinth hypoplasia	J:161968
	small placenta	J:161968
Ago2tm1.1Tara/Ago2tm1.1Tara Tg(Ins2-cre)23Herr/0 involves: 129P2/OlaHsd * C57BL/6J * CBA/J	abnormal pancreatic beta cell morphology	J:210552
	decreased pancreatic beta cell mass	J:210552
	decreased pancreatic beta cell number	J:210552
	decreased pancreatic beta cell proliferation	J:210552
	normal endocrine/exocrine gland phenotype	J:210552
	normal homeostasis/metabolism phenotype	J:210552
	improved glucose tolerance	J:210552
Ago2tm1.1Tara/Ago2tm1.1Tara Tg(KRT14-cre)1Efu/0 involves: 129P2/OlaHsd	no abnormal phenotype detected	J:183622
Ago2tm1.1Tara/Ago2tm1.1Tara Tg(Mx1-cre)1Cgn/0 involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * CBA	abnormal erythrocyte morphology	J:165967
	abnormal erythrocyte physiology	J:165967
	abnormal erythropoiesis	J:165967
	anemia	J:165967
	decreased erythrocyte cell number	J:165967
	decreased hematocrit	J:165967
	decreased hemoglobin content	J:165967
	decreased mean corpuscular hemoglobin	J:165967
	decreased mean corpuscular volume	J:165967
	enlarged spleen	J:165967
	increased number of Heinz bodies	J:165967
	increased red blood cell distribution width	J:165967
	reticulocytosis	J:165967
Ago2tm3.1Ghan/Ago2tm3.1Ghan involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr * CBA * Swiss Webster	abnormal proerythroblast morphology	J:161968
	decreased erythrocyte cell number	J:161968
	neonatal lethality, complete penetrance	J:161968
	pallor	J:161968
Gt(ROSA)26Sortm1(CAG-GFP/Eif2c2)Zjh/Gt(ROSA)26Sortm1(CAG-GFP/Eif2c2)Zjh involves: C57BL/6 * NZB	no abnormal phenotype detected	J:179351